Sun Pharma
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin.
| Company type | Public |
|---|---|
| ISIN | INE044A01036 |
| Industry | Pharmaceuticals |
| Founded | 1983 |
| Founder | Dilip Shanghvi |
| Headquarters | , India |
Area served | Worldwide |
Key people | Dilip Shanghvi (MD) |
| Products | Pharmaceutical drugs, generic drugs, antiviral drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health |
| Revenue | ₹44,520 crore (US$5.6 billion) (2023) |
| ₹9,408 crore (US$1.2 billion) (2023) | |
| ₹8,560 crore (US$1.1 billion) (2023) | |
| Total assets | ₹80,743 crore (US$10 billion) (2023) |
| Total equity | ₹55,995 crore (US$7.0 billion) (2023) |
Number of employees | 37,000+ (2021) |
| Website | sunpharma |
| Footnotes / references | |